Search Results - "H. Goker"

Haemostatic Actions of the Folkloric Medicinal Plant Extract Ankaferd Blood Stopper by Goker, H, Haznedaroglu, IC, Ercetin, S, Kirazli, S, Akman, U, Ozturk, Y, Firat, HC

“…Ankaferd Blood Stopper® (ABS), a standardized mixture of five plants, has been used historically as a haemostatic agent but its mechanism of action remains…”
Get full text

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation by Baron, F, Labopin, M, Blaise, D, Lopez-Corral, L, Vigouroux, S, Craddock, C, Attal, M, Jindra, P, Goker, H, Socié, G, Chevallier, P, Browne, P, Sandstedt, A, Duarte, R F, Nagler, A, Mohty, M

“…The impact of in vivo T-cell depletion on transplantation outcomes in patients transplanted with reduced-intensity conditioning (RIC) remains controversial…”
Get full text

A Personalized System for Conversational Recommendations by Thompson, C. A., Goker, M. H., Langley, P.

“…Searching for and making decisions about information is becoming increasingly difficult as the amount of information and number of choices increases…”
Get full text

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome by Nagler, A, Labopin, M, Berger, R, Bunjes, D, Campos, A, Socié, G, Kröger, N, Goker, H, Yakoub-Agha, I, Shimoni, A, Mohty, M, Rocha, V

“…I.v. BU is frequently used in the conditioning regimen prior to allogeneic hematopoietic SCT (allo-HSCT); however, overall outcomes, incidence of hepatic…”
Get full text

MANTLE CELL LYMPHOMA: TWO REFERENCE CENTER'S RESULTS by Goker, H., Okay, M., Meletli, O., Kelkitli, E., Tekin, F., Turgut, M., Demiroglu, H., Buyukasik, Y.

Get full text

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients by U. Malkan, H. Demiroglu, Y. Buyukasik, A. Karatas, E. Aladag, H. Goker

Get full text

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey by Salihoglu, A., Elverdi, T., Karadogan, I., Paydas, S., Ozdemir, E., Erdem, G., Karadurmus, N., Akyol, G., Kaynar, L., Yegin, ZA, Sucak, G., Ozkocaman, V., Topcuoglu, P., Ozcan, M., Birtas, E., Goker, H., Baslar, Z., Ferhanoglu, B.

“…Current treatment modalities can cure up to 70–80 % of patients with classical Hodgkin lymphoma. Approximately, 20–30 % of patients require further treatment…”
Get full text

THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T‐CELL NON‐HODGKIN'S LYMPHOMA: THE SINGLE CENTER EXPERIENCE by Sayınalp, N., Aladag, E., Okay, M., Ciftciler, R., Aksu, S., Demiroglu, H., Buyukasik, Y., Goker, H., Haznedaroglu, I.C., Ozcebe, O.I.

Get full text

Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia by E. Aladag, H. Goker, H. Demiroglu, S. Aksu, N. Sayınalp, I. Haznedaroglu, O. Ozcebe, Y. Buyukasık

Get full text

Acute phase reactants in chronic inflammation leading to secondary myelofibrosis in polycythemia vera and essential thrombocytosis by E. Aladag, I. Haznedaroglu, N. Sayinalp, H. Demiroglu, H. Goker, S. Aksu, O. Ozcebe, A. Ayhan, Y. Buyukasik

Get full text

Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT by Chevallier, P, Labopin, M, Milpied, N, Cornelissen, J J, Blaise, D, Petersen, E, Sandstedt, A, Goker, H, Socie, G, Rocha, V, Mohty, M

“…So far the impact of cytogenetics risk on outcome in the context of reduced intensity conditioning (RIC) allo-SCT has been poorly studied. We have identified…”
Get full text

Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1 by RODRIGUEZ, S, JAFER, O, COOPERS, C. S, CLARK, J, LOOIJENGA, L. H. J, SHIPLEY, J. M, GOKER, H, SUMMERSGILL, B. M, ZAFARANA, G, GILLIS, A. J. M, VAN GURP, Rjhlm, OOSTERHUIS, J. W, LU, Y.-J, HUDDART, R

“…Gain of 12p material is invariably associated with testicular germ cell tumors (TGCTs) of adolescents and adults, most usually as an isochromosome 12p. We…”
Get full text

P-19 THE CD34+ CELL COUNT EFFECTS THE CD34+ CELL COUNT by Akyol, T. Karaagac, Aksu, S, Goker, H, Ozcebe, O.I

Get full text

P-22 COMPARISON BETWEEN FILGRASTIM AND LENOGRASTIM FOR MOBILIZATION OF PBPCS IN HEALTHY ALLOGENEIC STEM CELL TRANSPLANTATION DONORS by Uz, B, Goker, H, Buyukasik, Y, Aksu, S, Sayinalp, N, Haznedaroglu, I.C, Tekin, F, Unal, S, Turgut, M, Ozcebe, O.I

Get full text

Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change by SUMMERSGILL, B, GOKER, H, WEBER-HALL, S, HUDDART, R, HORWICH, A, SHIPLEY, J

“…A series of adult testicular germ cell tumours consisting of eight seminomas, 14 non-seminomas (including two cell lines) and two combined tumours was analysed…”
Get full text

Synthesis, crystal and molecular structures of 1-n-butyl-2-(3′-chlorophenyl)-1H-benzimidazole-5-carbonitrile hemihydrate and 1-n-butyl-2-(3′,4′-dimethoxyphenyl)-1H-benzimidazole-5-carbonitrile by Kazak, C., Yilmaz, V. T., Goker, H., Kus, C.

“…Two types of 5‐cyanobenzimidazole derivatives with 1‐n‐butyl‐2‐(3′‐chlorophenyl), (C18H16N3Cl)2·H2O (1) and 1‐n‐butyl‐2‐(3′,4′‐dimethoxyphenyl), (C20H21N3O2)…”
Get full text

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation by Aksu, Salih, Buyukasik, Y., Ozcebe, O., Haznedaroglu, Ibrahim C., Uz, B., Sayinalp, N., Sayitoglu, M., Erbilgin, Y., Bektas, O., Eliacık, E., Goker, H.

“…The current treatment of chronic phase chronic myeloid leukemia (CML) consists of oral tyrosine kinase inhibitors (TKIs). However, high-risk CML may present…”
Get full text

PP-82 - Exercise program improves quality of life of the patients during the first 100 days following hematopoietic stem cell transplantation by Kabak, V. Yıldız, Goker, H., Duger, T.

Get full text

Exercise program improves quality of life of the patients during the first 100 days following hematopoietic stem cell transplantation by Kabak, V. Yıldız, Goker, H., Duger, T.

Get full text

The effects of experience during design problem solving by Goker, M H

“…Behavioural and physiological experiments to analsye the development, influence and application of experience during design problem solving are described. The…”
Get full text